Other Information
−Removed: During the quarter ended March 31,
−Removed: 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1
−Removed: trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
+Added: During the quarter ended June 30, 2024, no director
+Added: or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
+Added: as each term is defined in Item 408(a) of Regulation S-K.
Title of Document
−Removed: Debt Exchange Agreement dated February 5, 2024 with Cambridge MedSpace LLC
Rule 13a-14(a) Certification by Principal Executive Officer
14 unchanged sentences
IIOT-OXYS, Inc.
−Removed: July 12, 2024
+Added: August 19, 2024
/s/ Clifford L.
1 unchanged sentence
(Principal Executive Officer)
−Removed: July 12, 2024
+Added: August 19, 2024
/s/ Karen McNemar
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.